We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$221M |
| 2 |
GoDaddy
GDDY
|
+$159M |
| 3 |
Cigna
CI
|
+$135M |
| 4 |
Pfizer
PFE
|
+$132M |
| 5 |
HOLX
Hologic
HOLX
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$156M |
| 2 |
Apple
AAPL
|
+$148M |
| 3 |
Microsoft
MSFT
|
+$126M |
| 4 |
McDonald's
MCD
|
+$121M |
| 5 |
Danaher
DHR
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.95% |
| 2 | Technology | 21.4% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 11.77% |
| 5 | Financials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Fiverr
FVRR
$339M
| $37K | ﹤0.01% |
+1,590
| New | +$35.1K |
|
1177
Everspin Technologies
MRAM
$405M
| $37K | ﹤0.01% |
+7,021
| New | +$38.4K |
|
|
FRTA
1178
DELISTED
Forterra, Inc
FRTA
| $37K | ﹤0.01% |
+3,194
| New | +$31.1K |
|
1179
Riverview Bancorp
RVSB
$108M
| $36K | ﹤0.01% |
4,409
-2,237
| -34% | -$16.7K |
|
|
VNET
1180
VNET Group
VNET
$2.09B
| $35K | ﹤0.01% |
+4,892
| New | +$37.1K |
|
|
VIVO
1181
DELISTED
Meridian Bioscience Inc
VIVO
| $35K | ﹤0.01% |
3,588
-34,152
| -90% | -$321K |
|
|
MRUS
1182
DELISTED
Merus
MRUS
| $34K | ﹤0.01% |
+2,404
| New | +$38.7K |
|
|
MANT
1183
DELISTED
Mantech International Corp
MANT
| $33K | ﹤0.01% |
+412
| New | +$30.9K |
|
1184
Tilly's
TLYS
$128M
| $32K | ﹤0.01% |
+2,575
| New | +$27.2K |
|
1185
Par Pacific Holdings
PARR
$3.32B
| $30K | ﹤0.01% |
+1,297
| New | +$30.9K |
|
1186
AC Immune
ACIU
$240M
| $29K | ﹤0.01% |
3,374
-5,578
| -62% | -$37.2K |
|
|
MODV
1187
DELISTED
ModivCare
MODV
| $29K | ﹤0.01% |
491
-1,435
| -75% | -$87.6K |
|
|
PDCE
1188
DELISTED
PDC Energy, Inc.
PDCE
| $28K | ﹤0.01% |
1,081
+320
| +42% | +$7.68K |
|
1189
Impinj
PI
$5.6B
| $27K | ﹤0.01% |
1,032
-40,472
| -98% | -$1.26M |
|
|
BRG
1190
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $27K | ﹤0.01% |
+2,234
| New | +$26.6K |
|
1191
National Bank Holdings
NBHC
$1.9B
| $26K | ﹤0.01% |
+727
| New | +$25.6K |
|
|
SBOW
1192
DELISTED
SilverBow Resources, Inc.
SBOW
| $26K | ﹤0.01% |
+2,615
| New | +$24.8K |
|
|
WMGI
1193
DELISTED
Wright Medical Group Inc
WMGI
| $26K | ﹤0.01% |
850
-43,858
| -98% | -$1.15M |
|
1194
Americold
COLD
$4.27B
| $25K | ﹤0.01% |
717
-190,807
| -100% | -$7.02M |
|
1195
Mirum Pharmaceuticals
MIRM
$6.14B
| $25K | ﹤0.01% |
+1,011
| New | +$10.8K |
|
|
SRDX
1196
DELISTED
Surmodics
SRDX
| $24K | ﹤0.01% |
+572
| New | +$24.1K |
|
1197
America's Car Mart
CRMT
$26.9M
| $23K | ﹤0.01% |
209
-347
| -62% | -$33.6K |
|
1198
Ichor Holdings
ICHR
$2.56B
| $23K | ﹤0.01% |
+700
| New | +$20.9K |
|
1199
Central Garden & Pet Co Class A
CENTA
$2.44B
| $22K | ﹤0.01% |
+943
| New | +$21.2K |
|
|
DBVT
1200
DBV Technologies
DBVT
$847M
| $22K | ﹤0.01% |
+203
| New | +$16.2K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q4 2019 Portfolio in Review
As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.
- Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
- Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
- Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
- Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
- Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
- Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
- Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.
Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.